![]() |
市场调查报告书
商品编码
1776208
抛弃式内视镜的全球市场 - 市场考察,竞争情形,市场预测(2032年)Disposable Endoscopes - Market Insights, Competitive Landscape, and Market Forecast - 2032 |
全球一次性内视镜市场预计将从 2024 年的 26.5844 亿美元成长至 2032 年的 57.4875 亿美元,2025 年至 2032 年的复合年增长率为 10.19%。医疗保健环境中交叉污染和感染的增加推动了对更安全替代品的需求,例如无需再处理并可降低感染风险的一次性内视镜。此外,胃肠道、呼吸道和泌尿道等慢性疾病的发生率上升,也推动了用于诊断和治疗的内视镜手术数量的增加。此外,持续的产品开发,包括成像、便携性和人工智慧整合方面的进步,正在提高设备的性能和易用性。这些因素将显着推动2025年至2032年全球一次性内视镜市场的整体成长。
一次内视镜市场动态
根据世界卫生组织 (WHO) (2022) 的数据,每100名入住急诊医院的患者中,高收入国家约有7名,中低收入国家约有15名在住院期间至少发生一次医院相关感染 (HAI)。此外,报告估计,全球每年约有1.36亿例抗生素抗药性医院相关感染。
儘管可重复使用的内视镜经过再处理,但仍对传播传染病构成重大风险,包括抗药性细菌,如艰难梭菌、绿脓桿菌、抗甲氧西林金黄色葡萄球菌 (MRSA)、万古霉素肠球菌 (VRE) 和抗药性肠球菌 (CRE)。相较之下,一次性内视镜是一种无菌的一次性解决方案,消除了消毒失败的风险。因此,它们特别适用于重症监护病房 (ICU) 和急诊室等高风险环境。因此,对改善感染控制和更安全、更有效率的临床实践的需求正在推动对一次性内视镜的需求不断增长。
此外,呼吸系统、胃肠道和泌尿系统疾病的盛行率不断上升,进一步推动了一次性内视镜市场的发展。根据世界胃肠病学组织 (2023) 的数据,全球约有 49% 的女性和 36.6% 的男性符合至少一种功能性胃肠道疾病的诊断标准。同样,根据泌尿外科基金会 (2023) 的数据,英国约有一半的人患有泌尿系统疾病。这种盛行率的上升促使对诊断和治疗程序的需求增加,从而推动了对一次性内视镜解决方案的需求。
可重复使用内视镜虽然有效,但它们需要复杂、耗时且昂贵的再处理方案,并且存在交叉污染的风险。随着门诊手术中心和急诊内视镜手术的增多,一次性内视镜提供了一种实用的替代方案。一次性内视镜可降低感染风险,缩短手术时间,并提高病患吞吐量。
此外,主要产业参与者正在进行的产品开发活动也支持了市场扩张。例如,2022年5月,Ambu的无菌抛弃式支气管镜产品Ambu® aScope™ 5 Broncho获得了欧洲监管机构的批准。
因此,预计上述因素将在2025-2032预测期内共同推动一次性内视镜市场的成长。
然而,儘管存在这些优势,但某些限制可能会阻碍市场成长。一次性内视镜作为一次性使用设备,会产生医疗废弃物,引发环境和永续性的担忧。此外,由于其不适用于复杂的手术,可能会限制其在某些临床环境中的应用,从而严重限制其更广泛的市场扩张。
预计北美将主导整个一次性内视镜市场
预计到2024年,北美将引领全球一次性内视镜市场,原因包括医疗相关感染 (HAI) 发病率上升、泌尿系统和胃肠道疾病等慢性疾病盛行率上升以及医疗技术的持续进步。
本报告对全球一次性内视镜市场进行了研究和分析,提供了市场规模和预测、过去三年产品/服务发展、主要市场参与者以及可用机会等资讯。
Disposable Endoscopes Market by Product (Bronchoscopes, Gastroscopes, Duodenoscopes, Laryngoscope, and Others), Application (Pulmonology, Gastroenterology, Urology, ENT, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the increasing instances of cross-contamination and infections, increasing prevalence of chronic conditions, and rising product developmental activities globally.
The disposable endoscopes market was valued at USD 2,658.44 million in 2024, growing at a CAGR of 10.19% during the forecast period from 2025 to 2032 to reach USD 5,748.75 million by 2032. The increasing instances of cross-contamination and infections in healthcare settings are driving the demand for safer alternatives like disposable endoscopes, which eliminate the need for reprocessing and reduce infection risks. Alongside this, the rising prevalence of chronic conditions such as gastrointestinal, respiratory, and urological disorders is leading to a higher volume of diagnostic and therapeutic endoscopic procedures. Additionally, ongoing product development activities, including advancements in imaging, portability, and AI integration, are enhancing device performance and usability. Collectively, these factors are significantly boosting the overall market growth of disposable endoscopes worldwide during the forecast period from 2025 to 2032.
Disposable Endoscopes Market Dynamics:
According to data from the World Health Organization (2022), for every 100 patients admitted to acute-care hospitals, approximately 7 in high-income countries and 15 in low- and middle-income countries acquire at least one healthcare-associated infection (HAI) during their hospital stay. Furthermore, the same report estimates that around 136 million cases of healthcare-associated, antibiotic-resistant infections occur globally each year.
Reusable endoscopes, despite undergoing reprocessing, continue to pose a significant risk of transmitting infections such as Clostridioides difficile, Pseudomonas aeruginosa, and drug-resistant organisms like MRSA, VRE, and CRE. In contrast, disposable endoscopes offer a sterile, single-use solution that eliminates the risk of disinfection failures. This makes them particularly suitable for high-risk environments such as intensive care units (ICUs) and emergency departments. Consequently, the need for improved infection control and safer, more efficient clinical practices is fueling the growing demand for disposable endoscopes.
In addition, the increasing prevalence of respiratory, gastrointestinal, and urological conditions is further driving the disposable endoscope market. According to the World Gastroenterology Organization (2023), approximately 49% of females and 36.6% of males globally meet the criteria for at least one functional gastrointestinal disorder. Similarly, data from the Urology Foundation (2023) indicate that around one in two individuals in the United Kingdom experiences a urological condition. These rising disease rates are contributing to increased demand for diagnostic and therapeutic procedures, thereby boosting the need for disposable endoscopic solutions.
While reusable endoscopes are effective, they require complex, time-consuming, and costly reprocessing protocols, which also carry a risk of cross-contamination. With a growing number of endoscopic procedures being performed in outpatient settings, ambulatory surgical centers, and emergency departments, disposable endoscopes offer a practical alternative. They reduce infection risk, shorten turnaround times, and enhance patient throughput.
Moreover, ongoing product development efforts by key industry players are supporting market expansion. For example, in May 2022, Ambu received European regulatory approval for its Ambu(R) aScope(TM) 5 Broncho, a line of sterile, single-use bronchoscopes.
Therefore, the factors outlined above are expected to collectively drive the growth of the disposable endoscopes market during the forecast period from 2025 to 2032.
However, despite these advantages, certain limitations could hinder market growth. As single-use devices, disposable endoscopes contribute to medical waste, raising environmental and sustainability concerns. Additionally, their limited suitability for complex procedures may restrict adoption in some clinical settings, serving as key constraints on broader market expansion.
Disposable Endoscopes Market Segment Analysis:
Disposable Endoscopes Market by Product (Bronchoscopes, Gastroscopes, Duodenoscopes, Laryngoscope, and Others), Application (Pulmonology, Gastroenterology, Urology, ENT, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the products segment of disposable endoscopes, the bronchoscopes category is expected to have a significant revenue share in the year 2024. This can be ascribed to their advantages, such as the use of bronchoscopes in the diagnosis and treatment of tumors and bronchial cancers, airway blockage (obstruction), narrowed areas in the airways, and interstitial pulmonary diseases, among others.
Another key aspect contributing in the growing demand for bronchoscopes is that it also comprises of increased detection and improved access, reaching to the most distant regions of the lungs, earlier diagnosis of lung tumors, better treatment decisions, reduced risk associated with complications, and eliminating the risk associated with invasive surgeries, all of the advantages possible due to the presence of navigational bronchoscopy.
Given the advantages associated with navigational bronchoscopy, there has been increasing acceptance among end users, which in turn has led to a rise in the number of new product launches in the market. For example, in April 2023, Verathon, a leading global medical device company, announced the launch of the BFlex(TM) 2, the next generation of its single-use bronchoscope portfolio. The upgraded BFlex 2 series features four scope sizes and incorporates enhanced capabilities aimed at helping clinicians deliver improved care for both adult and pediatric patients across various hospital settings.
Therefore, driven by these advancements and growing clinical adoption, the bronchoscopes segment is anticipated to experience significant growth, thereby contributing substantially to the overall expansion of the disposable endoscopes market during the forecast period from 2025 to 2032.
North America is expected to dominate the overall disposable endoscopes market:
North America is expected to lead the global disposable endoscopes market in 2024, driven by several key factors, including the rising incidence of healthcare-associated infections (HAIs), the growing prevalence of chronic conditions such as urological and gastrointestinal disorders, and continued advancements in healthcare technology.
One of the primary drivers in the region is the increasing risk of cross-contamination associated with reusable endoscopes. According to data from the Centers for Disease Control and Prevention (CDC, 2024), approximately 1 in 31 hospital patients in the United States acquires at least one healthcare-associated infection. Similarly, recent data from the Provincial Infection Control Network of British Columbia (2025) reported that in Canada, 1 in 9 hospital patients contract an HAI, with over 220,000 such cases occurring annually. These statistics underscore the growing threat of infection in clinical settings, especially where reusable devices are used. Disposable endoscopes, being sterile and single-use, eliminate the risk of cross-contamination and are increasingly preferred in high-risk environments such as ICUs and emergency departments.
Additionally, technological innovations and regulatory support are strengthening the regional market. North America has witnessed a surge in product development and regulatory approvals, supported by a well-established healthcare infrastructure and the strong presence of key medical device companies. These conditions create a favorable ecosystem for market expansion.
For example, in May 2024, Olympus Corporation announced the launch of the DVM-B2 Digital Video Monitor, an integrated video processor and monitor specifically designed for use with single-use endoscopes. This system supports applications in bronchoscopy and ENT procedures and is compatible with Olympus's H-SteriScope(TM) Single-use Flexible Bronchoscopes and E-SteriScope(TM) Single-use Flexible Rhinolaryngoscopes. The device, manufactured by Hunan Vathin Medical Instruments Co., Ltd., is distributed exclusively by Olympus America, Inc., further reinforcing the company's commitment to advancing disposable endoscopy solutions in the region.
Moreover, increased awareness of infection control, favorable reimbursement frameworks, and ongoing partnerships and commercialization strategies among major industry players are expected to accelerate market growth further.
In conclusion, the convergence of rising HAI rates, technological innovation, growing demand for safer diagnostic tools, and strong regional healthcare investment is expected to make North America a dominant force in the disposable endoscopes market during the forecast period from 2025 to 2032.
Disposable Endoscopes Market key players:
Some of the key market players operating in the disposable endoscopes market include Olympus Corporation, Boston Scientific Corporation, Ambu Inc., ProSurg Inc., Baxter, Teleflex Incorporated, Flexicare Medical Limited, AUG Medical, NeoScope Inc., Xenocor Inc., 3NT Medical, Corinth MedTech, Inc., PENTAX Medical, Daichuan Medical, Omnivision, Verathon, and others.
Recent Developmental Activities in the Disposable Endoscopes Market:
Key takeaways from the disposable endoscopes market report study:
Target audience who can benefit from this disposable endoscopes market report study:
Frequently Asked Questions for the Disposable Endoscopes Market: